{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:34:10Z","timestamp":1793799250033,"version":"4.6.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI25\/001812"],"award-info":[{"award-number":["PI25\/001812"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["FPU21\/02012"],"award-info":[{"award-number":["FPU21\/02012"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["FPU20\/02798"],"award-info":[{"award-number":["FPU20\/02798"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.esmoop.2026.108607","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:52:01Z","timestamp":1792522321000},"page":"108607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Germline pharmacogenetic variants associated with trastuzumab deruxtecan-induced interstitial lung disease in advanced breast cancer: PROCURE project"],"prefix":"10.1016","volume":"11","author":[{"given":"A.","family":"Arenas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8296-5065","authenticated-orcid":false,"given":"C.","family":"Saura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Alva-Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5398-7177","authenticated-orcid":false,"given":"J.","family":"de Nicol\u00e1s-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6601-3360","authenticated-orcid":false,"given":"M.","family":"Gion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Cejalvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Llabr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7623-1583","authenticated-orcid":false,"given":"J.","family":"Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4531-5877","authenticated-orcid":false,"given":"A.","family":"Falc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1485-5080","authenticated-orcid":false,"given":"S.","family":"Pernas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0742-1150","authenticated-orcid":false,"given":"A.","family":"L\u00f3pez de Sa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hinojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Curiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6398-1641","authenticated-orcid":false,"given":"J.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2105-1213","authenticated-orcid":false,"given":"B.","family":"Cantos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1566-9586","authenticated-orcid":false,"given":"M.J.","family":"Echarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Gallegos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1614-1030","authenticated-orcid":false,"given":"C.","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7816-7589","authenticated-orcid":false,"given":"S.","family":"Escriv\u00e1-de-Roman\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3556-6947","authenticated-orcid":false,"given":"B.","family":"Fullana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4821-4081","authenticated-orcid":false,"given":"M.A.","family":"Cobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2253-0980","authenticated-orcid":false,"given":"L.","family":"Joval-Ramentol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ortiz-Heras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8431-3183","authenticated-orcid":false,"given":"T.","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8934-6627","authenticated-orcid":false,"given":"C.","family":"Valdivia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Villacampa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Ciruelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8750-7338","authenticated-orcid":false,"given":"C.","family":"Rodriguez-Antona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5255-6620","authenticated-orcid":false,"given":"R.","family":"S\u00e1nchez-Bayona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.esmoop.2026.108607_bib1","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMoa2115022","article-title":"Trastuzumab deruxtecan versus trastuzumab emtansine for breast cancer","volume":"386","author":"Cort\u00e9s","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108607_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2203690","article-title":"Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer","volume":"387","author":"Modi","year":"2022","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.esmoop.2026.108607_bib3","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMoa2407086","article-title":"Trastuzumab deruxtecan after endocrine therapy in metastatic breast cancer","volume":"391","author":"Bardia","year":"2024","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.esmoop.2026.108607_bib4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa2508668","article-title":"Trastuzumab deruxtecan plus pertuzumab for HER2-positive metastatic breast cancer","volume":"394","author":"Tolaney","year":"2026","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.esmoop.2026.108607_bib5","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJMoa2514661","article-title":"Trastuzumab deruxtecan in residual HER2-positive early breast cancer","volume":"394","author":"Loibl","year":"2026","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.esmoop.2026.108607_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/COC.0000000000001126","article-title":"Safety and efficacy of trastuzumab deruxtecan for metastatic HER2+ and HER2-low breast cancer: an updated systematic review and meta-analysis of clinical trials","volume":"47","author":"Qureshi","year":"2024","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.esmoop.2026.108607_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104355","article-title":"Trastuzumab deruxtecan in breast cancer","volume":"198","author":"Mart\u00edn","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"10.1016\/j.esmoop.2026.108607_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.101613","article-title":"Incidence of interstitial lung disease and cardiotoxicity with trastuzumab deruxtecan in breast cancer patients: a systematic review and single-arm meta-analysis","volume":"8","author":"Soares","year":"2023","journal-title":"ESMO Open"},{"issue":"12","key":"10.1016\/j.esmoop.2026.108607_bib9","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1001\/jamaoncol.2021.3595","article-title":"Interstitial lung disease induced by anti-ERBB2 antibody-drug conjugates: a review","volume":"7","author":"Tarantino","year":"2021","journal-title":"JAMA Oncol"},{"issue":"11","key":"10.1016\/j.esmoop.2026.108607_bib10","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1158\/0008-5472.CAN-24-2021","article-title":"Perivascular niche-resident alveolar macrophages promote interstitial pneumonitis related to trastuzumab deruxtecan treatment","volume":"85","author":"Wei","year":"2025","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.esmoop.2026.108607_bib11","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1248\/bpb.30.2365","article-title":"Relationship between drug release of DE-310, macromolecular prodrug of DX-8951f, and cathepsins activity in several tumors","volume":"30","author":"Shiose","year":"2007","journal-title":"Biol Pharm Bull"},{"issue":"20","key":"10.1016\/j.esmoop.2026.108607_bib12","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1158\/1078-0432.CCR-15-2822","article-title":"DS-8201a, a novel HER2-targeting ADC with a novel DNA topoisomerase I inhibitor, demonstrates a promising antitumor efficacy with differentiation from T-DM1","volume":"22","author":"Ogitani","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.esmoop.2026.108607_bib13","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s40265-020-01281-4","article-title":"Trastuzumab deruxtecan: first approval","volume":"80","author":"Keam","year":"2020","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.esmoop.2026.108607_bib14","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/cpt.2557","article-title":"The clinical pharmacogenetics implementation consortium guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and statin-associated musculoskeletal symptoms","volume":"111","author":"Cooper-DeHoff","year":"2022","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108607_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cpt.113","article-title":"Clinical pharmacogenetics implementation consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing","volume":"98","author":"Birdwell","year":"2015","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.esmoop.2026.108607_bib16","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/s41431-022-01243-2","article-title":"Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction between UGT1A1 and irinotecan","volume":"31","author":"Hulshof","year":"2023","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"10.1016\/j.esmoop.2026.108607_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2026.107695","article-title":"Analysis of UGT1A1 germline variants in patients with advanced breast cancer treated with trastuzumab-deruxtecan: results from the PROCURE project","volume":"11","author":"S\u00e1nchez-Bayona","year":"2026","journal-title":"ESMO Open"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108607_bib18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/pds.669","article-title":"Classification of ADRs: a proposal for harmonization and differentiation based on the experience of the Comprehensive Hospital Drug Monitoring Bern\/St. Gallen, 1974-1993","volume":"11","author":"Hunziker","year":"2002","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"10.1016\/j.esmoop.2026.108607_bib19","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-B\u22175701 screening for hypersensitivity to abacavir","volume":"358","author":"Mallal","year":"2008","journal-title":"N Engl J Med"},{"issue":"suppl 16","key":"10.1016\/j.esmoop.2026.108607_bib20","doi-asserted-by":"crossref","first-page":"12125","DOI":"10.1200\/JCO.2025.43.16_suppl.12125","article-title":"Germline determinants of pneumonitis in patients with cancer treated with antibody drug conjugates","volume":"43","author":"Yekeduz","year":"2025","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108607_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"18","key":"10.1016\/j.esmoop.2026.108607_bib22","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1093\/bioinformatics\/btab186","article-title":"LocusZoom.js: interactive and embeddable visualization of genetic association study results","volume":"37","author":"Boughton","year":"2021","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108607_bib23","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s12282-025-01814-3","article-title":"Real-world analysis of interstitial lung disease\/pneumonitis in Japanese patients with breast cancer receiving trastuzumab deruxtecan","volume":"33","author":"Tsurutani","year":"2026","journal-title":"Breast Cancer"},{"issue":"9","key":"10.1016\/j.esmoop.2026.108607_bib24","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1111\/cas.16234","article-title":"Trastuzumab deruxtecan versus trastuzumab emtansine in Asian patients with HER2-positive metastatic breast cancer","volume":"115","author":"Iwata","year":"2024","journal-title":"Cancer Sci"},{"issue":"D1","key":"10.1016\/j.esmoop.2026.108607_bib25","doi-asserted-by":"crossref","first-page":"D925","DOI":"10.1093\/nar\/gkae977","article-title":"The evolution of dbSNP: 25 years of impact in genomic research","volume":"53","author":"Phan","year":"2025","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.esmoop.2026.108607_bib26","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3390\/pharmaceutics17050542","article-title":"Dose-limiting toxicities and the maximum tolerated dose of irinotecan based on UGT1A1 genotypes: a systematic review","volume":"17","author":"D\u00edaz-Villamar\u00edn","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.esmoop.2026.108607_bib27","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejca.2021.12.009","article-title":"UGT1A1 genotype-guided dosing of irinotecan: a prospective safety and cost analysis in poor metaboliser patients","volume":"162","author":"Hulshof","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.esmoop.2026.108607_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejca.2020.09.007","article-title":"Pre-therapeutic UGT1A1 genotyping to reduce the risk of irinotecan-induced severe toxicity: ready for prime time","volume":"141","author":"Hulshof","year":"2020","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108607_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/tan.70547","article-title":"HLA-F: a non-classical gene with growing interest","volume":"107","author":"Gr\u00fcnen","year":"2026","journal-title":"HLA"},{"issue":"9","key":"10.1016\/j.esmoop.2026.108607_bib30","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/ni.3513","article-title":"Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1","volume":"17","author":"Garcia-Beltran","year":"2016","journal-title":"Nat Immunol"},{"issue":"9","key":"10.1016\/j.esmoop.2026.108607_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163297","article-title":"HLA-F and MHC-I open conformers bind natural killer cell Ig-like receptor KIR3DS1","volume":"11","author":"Burian","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.esmoop.2026.108607_bib32","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.4049\/jimmunol.1300081","article-title":"HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors","volume":"191","author":"Goodridge","year":"2013","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.esmoop.2026.108607_bib33","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1002\/1521-4141(200012)30:12<3552::AID-IMMU3552>3.0.CO;2-L","article-title":"Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors","volume":"30","author":"Lepin","year":"2000","journal-title":"Eur J Immunol"},{"issue":"6982","key":"10.1016\/j.esmoop.2026.108607_bib34","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.esmoop.2026.108607_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100554","article-title":"Pooled analysis of drug-related interstitial lung disease and\/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies","volume":"7","author":"Powell","year":"2022","journal-title":"ESMO Open"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926025524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926025524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:20:33Z","timestamp":1793798433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702926025524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2059702926025524"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108607","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Germline pharmacogenetic variants associated with trastuzumab deruxtecan-induced interstitial lung disease in advanced breast cancer: PROCURE project","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108607","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"108607"}}